Healthcare-Associated Pneumonia.
10.4046/trd.2011.70.2.105
- Author:
Heung Bum LEE
1
;
Hyo Jin HAN
Author Information
1. Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea. lhbmd@jbnu.ac.kr
- Publication Type:Review
- Keywords:
Healthcare;
Pneumonia
- MeSH:
Anti-Bacterial Agents;
Delivery of Health Care;
Humans;
Pneumonia;
Risk Factors
- From:Tuberculosis and Respiratory Diseases
2011;70(2):105-112
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pneumonia is frequently encountered in the clinical fields, both as a cause for admission and as a complication of the underlying disorder or as the course of treatment. Pneumonia is the second most common hospital-acquired infection and is associated with the highest morbidity and mortality rates among hospital-acquired infections. The guidelines for the management of hospital-acquired pneumonia by the American Thoracic Society include identifying individuals who have recently received antibiotics therapy or have been in medical facilities; these individuals are at higher risk for infection with multiple drug resistant organisms. Individuals, who have acquired pneumonia according to this clinical scenario, have what is known as healthcare-associated pneumonia (HCAP). Patients with HCAP should be considered to have potentially drug-resistant pathogens and should receive broad spectrum empiric antibiotic therapy directed at the potentially resistant organisms. In this paper, the diagnosis, risk factors, and treatment of HCAP are discussed.
